Clinical Trial Update: Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating daylight photodynamic therapy with aminolevulinic acid for actinic keratosis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• aminolevulinic acid (ALA) (aminolevulinic acid)

Snippet

Sponsor: University of California, Irvine | Conditions: Actinic Keratosis | Phase 4 | Status: COMPLETED | Results posted: 2024-06-27